Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

37.04
BATS BZX Real-Time Price
As of 1:47pm ET
 +0.09 / +0.24%
Today’s Change
33.60
Today|||52-Week Range
54.23
-2.91%
Year-to-Date
EpiPen Competitor, Auvi-Q, Will Hit the Market in February
Jan 19 / TheStreet.com - Paid Partner Content
Mylan/Biocon's Herceptin Biosimilar under Review in the U.S.
Jan 12 / Zacks.com - Paid Partner Content
Integrated Investment Consultants, LLC Buys Vanguard FTSE Emerging Markets, Mylan NV,...
Jan 18 / GuruFocus News - Paid Partner Content
Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again
Jan 12 / Zacks.com - Paid Partner Content
Examining Volkswagen and Fiat Chrysler's Emissions Cheating Scandals
Jan 13 / Zacks.com - Paid Partner Content
Cigna is no longer covering pricey EpiPen
Jan 11 / CNNMoney.com
Fifth Street Asset Management, Cray, CVS Health, Mylan and Impax Laboratories highlig...
Jan 13 / Zacks.com - Paid Partner Content
Valeant Streamlines Portfolio with Skincare Brands Sale
Jan 11 / Zacks.com - Paid Partner Content
Will This Be a Genius or Foolish Move for Johnson & Johnson?
Jan 13 / MotleyFool.com - Paid Partner Content
Trump: Drug companies 'getting away with murder'
Jan 11 / CNNMoney.com
Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News
Jan 13 / Zacks.com - Paid Partner Content
Valeant to Sell Dendreon Unit to Sanpower for $820 Million
Jan 10 / Zacks.com - Paid Partner Content
Stock Market Roundup, Jan. 12: AMZN Jobs, FCAU Cheating, AKS & X Tank
Jan 12 / Zacks.com - Paid Partner Content
Momenta (MNTA) to Receive $50M Under CSL Collaboration
Jan 06 / Zacks.com - Paid Partner Content
CVS Debuts Cheap EpiPen Alternative
Jan 12 / Zacks.com - Paid Partner Content
These big companies had a terrible 2016
Dec 27 / CNNMoney.com
CVS cuts cost for generic EpiPen competitor
Jan 12 / CNNMoney.com